Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study
Authors:
Open Access
- 26 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 149 (2) , 60-65
Abstract
No abstract availableKeywords
Funding Information
- Japan Research Foundation for Clinical Pharmacology
This publication has 18 references indexed in Scilit:
- A Randomized, Controlled Trial of Oral Propranolol in Infantile HemangiomaNew England Journal of Medicine, 2015
- RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-OldsPediatrics, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Propranolol Accelerates Adipogenesis in Hemangioma Stem Cells and Causes Apoptosis of Hemangioma Endothelial CellsPlastic and Reconstructive Surgery, 2012
- Propranolol induces apoptosis of human umbilical vein endothelial cells through down-regulation of CD147British Journal of Dermatology, 2012
- The psychosocial impact of an infantile haemangioma on children and their parents: Table 1Archives of Disease in Childhood, 2012
- Comparison of quantitative light‐induced fluorescence, digital photography and transverse microradiography for quantification of enamel remineralizationAustralian Dental Journal, 2012
- Topical Timolol for Infantile Hemangiomas: Putting a Note of Caution in “Cautiously Optimistic”Pediatric Dermatology, 2012
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989